Androgen receptor antagonists
US7064207B2 · kind B2 · utility
3Cited by
3References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2004 |
| Grant date | Jun 20, 2006 |
| Priority date | — |
| Expiry date | Jul 21, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to a new class of 6-sulfonamido-quinolin-2-one and 6-sulfonamido-2-oxo-chromene derivatives to their use as androgen antagonists, and to relieve conditions associated with inappropriate activation of the androgen receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.